Alto Neuroscience Inc. (ANRO)
NYSE
Closed
Oct 7, 2026
Day's Range
23.3252 wk Range
5.22Overview - ANRO - Alto Neuroscience Inc.
Key Statistics
Valuation
Enterprise Value
752.76M
P/E (Trailing)
‪-11.34‬
P/E (Forward)
‪-7.54‬
PEG Ratio
‪-7.54‬
Price / Book
‪3.96‬
EV / EBITDA
‪-8.59‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-26.78%‬
Return on Equity
‪-49.16%‬
Ownership
Shares Outstanding
35.09M
Float
29.64M
Short % of Shares Outstanding
‪12.46%‬
Held by Insiders
‪4.07%‬
Held by Institutions
‪87.09%‬
Price stats
Beta
‪1.15‬
50-Day Avg
‪30.90‬
200-Day Avg
‪23.72‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
11 analysts
Average price target
‪$ 38.38‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ANRO - Alto Neuroscience Inc.
Peers - ANRO - Alto Neuroscience Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NYSE.
- ANRONYSEAlto Neuroscience Inc.973.20MMarket Cap+73.63%52-week change-11.34P/E (Trailing)‪0.00%‬Profit Margin
- BIONYSEBio-Rad Laboratories Inc.9.87BMarket Cap+16.25%52-week change44.96P/E (Trailing)‪8.58%‬Profit Margin
- BHVNNYSEBiohaven Ltd.1.94BMarket Cap-23.39%52-week change-1.88P/E (Trailing)‪0.00%‬Profit Margin
- BSTNYSEBlackRock Science and Technology Trust1.76BMarket Cap+21.83%52-week change7.02P/E (Trailing)‪0.00%‬Profit Margin
- BCXNYSEBlackRock Resources & Commodities Strategy Trust991.85MMarket Cap+22.29%52-week change4.66P/E (Trailing)‪0.00%‬Profit Margin
- ATTONYSEAttovia Therapeutics Inc.783.83MMarket Cap-27.55%52-week change-7.23P/E (Trailing)‪0.00%‬Profit Margin
- ARMPNYSEArmata Pharmaceuticals, Inc.130.88MMarket Cap+9.09%52-week change-0.73P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - ANRO - Alto Neuroscience Inc.
About
Alto Neuroscience Inc. is a clinical-stage biopharmaceutical company focused on developing precision medicines for neuropsychiatric disorders. Alto Neuroscience applies its Precision Psychiatry Platform to analyze brain biomarkers, EEG activity, neurocognitive assessments, wearable data, and other patient-specific…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
